Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 6
Submit an article Journal homepage
127
Views
39
CrossRef citations to date
0
Altmetric
Research Article

Gene Expression Profiling in Chronic Myeloid Leukemia Patients Treated with Hydroxyurea

Hana Bruchova Institute of Hematology and Blood Transfusion, Department of Molecular Genetics, U nemocnice 1, 128 20 Prague 2, Czech Republic
,
Tereza Borovanova Institute of Hematology and Blood Transfusion, Department of Molecular Genetics, U nemocnice 1, 128 20 Prague 2, Czech Republic
,
Hana Klamova Institute of Hematology and Blood Transfusion, Department of Molecular Genetics, U nemocnice 1, 128 20 Prague 2, Czech Republic
&
Radim Brdicka Institute of Hematology and Blood Transfusion, Department of Molecular Genetics, U nemocnice 1, 128 20 Prague 2, Czech Republic
Pages 1289-1295 | Published online: 01 Jul 2009

  • Bazzoni, G., Carleso, N., Griffin, J.D. and Hemler, M.E. (1996) "Bcr/Abl expression stimulates integrins function in hematopoitic cell lines". J. Clin Investig. 98, 521-528.
  • Zhao, R.C., Tarone, C. and Verfuulie, C.M. (1997) "Presence of the adhesion inhibitory ? 21B integrin isoform on CMI. but not normal progenitors is at least in part responsible for decreased CML progenitor adhesion", Blood 90(1). 393a.
  • Bedi, A., Zehnbauer, U.A., Barber, J.P., Sharkis, S.J. and Jones. R.J. (1994) "Inhibition of apoptosis by BCR/ABL in chronic myeloid leukemia". Blood 83, 2034-2044.
  • Cortez, D., Stoica, G., Pierce, J.H. and Pendergast, A.M. (1996) "The BCR/ABI. tyrosine kinase inhibits apoptosis by activation a Ras-dependent signaling pathway". Oncogene 13, 2589-2594.
  • Cambier, N., Chopra, R., Strasser, A., Metcalf, D. and Elefanty, A.G. (1998) "BCR/ABL pathways mediating cytokine independence and protection against apopoptosis in murine hematopotetic cells in dose-dependent manner", Oncogene 16, 335-348.
  • Giralt, S.A., Kantarjian, H.M. and Talpaz, M (1995) "Treatment of chronic myelogenous leukemia". Semin. Oncol. 22, 396-404.
  • Hehlmann, R. and Heimpel, H. (1996) "Current aspects of drug therapy in Philadelphia--positive CML: correlation of tumor burden with survival", Leuk. Lymphoma 22, 161-167.
  • Hehlmann, R., Heimpel, H. and Hasford, J. (1994) "Randomized comparison of imerferon alpha with bushulfan and hydroxyurea in chronic myelogenous leukemia". Blood 84, 4064-4077.
  • Thiele, J., Kvasnicka, H.M., Schmitt-Graeff, A., Bundschuh, S., Biermann, T., Roessler, G., Wasmus, M., Diehl, V., Zankovich, R. and Shacfer, H.H. (2(XX)) "Effects of chemotherapy (hydroxyureabusulfan) and Interferon alpha on bone marrow morphologic features in chronic myelogenous leukemia". Am. J. Clin. Pathol. 114, 57-65.
  • Chomczynsky, P. and Sacchi, N. (1987) "Single step method of RNA isolation by acid quanidin-isothiocyanate-phcnol-chloroform extraction". Anal. Biochem. 162, 156-159.
  • Boyum. A. (1968) "Isolation of mononuclear cells and granulocyies from human blood". Scand. J. Clin. Lab. Investig. 21 (Suppt. 97). 77-89.
  • Hardy, K. and Chaudhri, G. (1997) "Activation and signal transduction via miiogcn-activatcd protein (MAP) kinases in T lymphocytes", Immiuiol. Cell. Biol. 75, 528-545.
  • Chopra, R., Pu, Q.Q. and Elefanty, A.C. (1999) "Biology of BCR-ABL". Blood Rev. 13, 211-229.
  • Raitano, A.B., Halpern, J.R., Hamboch, T.M. and Sawyers, C.L. (1995) "The Bcr-Abl leukaemia oncogene activates Jun kinase and requires Jun for transformation". Proc. Natl Acad Sci. USA 92, 11746-11750.
  • Rooprai, H.K. and McCornuck, D. (1997) "Proteases and their inhibitors in human brain tumour).". Anticancer Res. 17, 4151-4162.
  • O-charoenral, P., Rhys-Evans, P., Court, WJ., Box, G.M. and Eccles, S.A. (1999) "Differential modulation of proliferation. matrix metalloproteinase expression and invasion of human head and neck squamous carcinoma cells by c-erbB ligands". Clin. Exp. Metastasis 17(7). 631-639.
  • Kossakowska, A.E., Urbanski, S.J., Watson, A., Hayden, L.J. and Edwards. D.R. (1993) "Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas". Oncol. Res. 5, 19-28.
  • Pang, M., Abe, T., Fujihara, T. Mori, S., Tsuzaka, K., Amano, K., Koide, J. and Takeuehi, T. (1998) "Up-regulation of alphaEbeta7, a novel integrin adhesion molecule, on T cells from systemic lupus erythcmatosus patients with specific epithelial involvement". Arthritis Rheum 41(8), 1456-1463.
  • Troussard, X., Muloisel, F. and Flandrin, G. (1998) "Hairy cell leukemia. What is new forty years after the first description?". Hematol. Cell. Ther. 40(4). 139-148.
  • Ito, M., Tsurusawa, M., Zha, Z., Kawai, S., Takasaki, Y. and Fujimoto, T. (1992) "Cell proliferation in childhood acute leukemia. Comparison of Ki-67 and proliferating cell nuclear antigen immunocytochemical and DNA flow cytometric analysis". Cancer 69(3), 655-661.
  • Takasaki, Y, Robinson, WA. and Tan, E.M. (1984) "Proliferating cell nuclear antigen in blast crisis cells of patients with chronic myeloid leukemia". J. Natl. Cancer Inst. 73(3). 655-661.
  • Deininger, M.W.N., Goldman, J.M. and Melo, J.V. (2000) "The molecular biology of chronic myeloid leukemia". Blood 96(10). 3343-3356.
  • Maio, M., Brasoveanu, L.I., Coral, S., Sigalotti, L., Lamaj, E., Gasparollo, A., Vistntin, A., Altomonte, M. and Fonsati, E. (1998) "Structure, distribution, and functional role of protectin (CD59) in complement-susceptibility and immunotherapy of human malignancies". Int. J. Oncol. 13(2), 305-318.
  • Chen, W., Thu, J., Liu, J. and Tan, S. (1998) "Methylation of pI6 gene in hematological malignancies". Chin. Med. J. 111(11). 1028-1030.
  • Guran, S., Bahce, M., Beyan, C., Korkmaz, K. and Yalcin, A. (1998) "P53, pl5INK4B, p16INK4A and p57KIP2 mutations during the progression of chronic myeloid leukemia". Haemaiologica 29(3). 181-193.
  • dc Groot, R.P. Raaijmakers, J.A., Lammers, J.W. Jove, R and Koendertnan, L. (1999) "STATS activation by BCR-ABL contributes to transformation of K562 leukemia cells". Blood 94. 1108-1112.
  • Shuai, K., Halpern, J., ten Hoeve, J., Rao, X. and Sawyers, C.L. (1996) "Constitutive activation of STATS by the BCR ABL oncogene in chronic myelogenoux leukemia", Oncogene 13(2). 247-254.
  • Eymin, B., Dubrez, L., Allouche, M. and Solary, E. (1997) "Increased gadd153 messenger level is associated with apoplosis in human leukemic cells treated with etoposide". Cancer Res. 57(4), 686-695.
  • Earp, H.S., Dawson, T.L., Li. X. and Yu, H. (1995) "Helerodimerization and functional interaction between EGF receptor family members: u new signaling paradigm with implications for breast cancer research", Breast Cancer Res. Treat. 35(1), 115-132.
  • Gullick, W.J. (1996) "The c-erbB3/HER3 receptor in human cancer". Cancer Surg 27, 339-349
  • Groten, T., Kreienberg, R., Kalka, I., Huber, L. and Wedlich, D. (2000) "Altered subcellular distribution of cadherin-5 in endothelial cells caused by the serum of pre-eclamplic palients". Mol. Hum. Reprod. 6(11), 1027-1032.
  • Wetiler, M., Kurzrock, R., Estrov, Z., Kanlarjian, H., Gisslinger, H., Underbrink, M.P. and Talpaz, M. (1994) "Altered levels of interleukin-1 beta and interleukin-1 receptor antagonist in chronic myelogenous leukemia: clinical and prognostic correlates". Blood 84(9), 3142-3147.
  • Howard, A.D., Chartrain, N., Ding, C.F., Kostura, M.J., Limjuco. G., Schmidt, J.A. and Tocci, M.J. (1991) "Probing the role of interleukin-1 beta convertase in interleukin-1 beta secretion". Agents Actions Suppl. 35, 77-83.
  • Symons, M. (1996) "Rho family GTPases: the cytoskeleton and beyond", Trends Biochem. Sci. 21(5). 178 181.
  • Scott, L.M., Mueller, I., and Collins, S.J. (1996) "E3. a hematopoietic-specific transcript directly regulated by the retinoic acid receptor alpha". Blood 88(7), 2517-2530.
  • Sanlucci, M.A., Ripalti, A., di Paola, M.C., Miaoulli, A.M., Facurti, E., Campanini, F., Gamben, B. and Tura, S (1999) "Procedure for the quantilation of Gadd45 expression levels in clonal hematopoietic progenitor cells by competitive polymerase chain reaction". Clin. Biochem. 32(1), 1-8.
  • Qian, Y.W., Wang, Y.C., Hollingsworth, Jr. R.E., Jones, D., Ling, N. and Lee, E.Y. (1993) "A retinoblastoma-hinding protein related to a negative regulator of Ras in yeast". Nature 346(6438). 648-652.
  • Gerber, H.P., Condorelli, F., Park, J. and Ferrara, N. (1997) "Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1. but not Flk-1/KDR, is up-regulated by hypoxia". J Biol. Chem. 272(38). 23659-23667.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.